Precision Healthcare’s Fady Hannah-Shmouni on extending healthspan through mitigating genetic risks and advancing AI-driven endocrine care.
Dr Fady Hannah-Shmouni, an expert in endocrinology and longevity medicine, is at the forefront of integrating advanced technologies into healthspan science. Through his work in precision medicine and AI-driven healthcare solutions, he is aiming to redefine how we monitor, predict and optimize hormonal health to extend vitality and longevity. As the founder of Healthspan Digital Inc, he is spearheading the development of innovative tools – from AI-powered smart mirrors to modular multi-omics analysis platforms – that empower individuals and businesses to take a proactive approach to aging. His research and clinical work span genetic endocrinology, metabolic health and interventions aimed at bridging the gap between lifespan and healthspan.
The Global Healthspan Summit kicked off today in Riyadh; set to convene world leaders in science, investment and policy, discussions will focus on translating breakthroughs in aging research into real-world applications. Among the key panels, The Technology in Healthspan Exchange will highlight the latest MIT Technology Review (Spain) insights on emerging longevity technologies. Experts will explore the potential of AI, epigenetic reprogramming and theranostics in reshaping healthspan interventions, while also addressing critical ethical considerations around accessibility and empowerment. Moderated by Pedro Moneo (CEO and Founder, Opinno), the panel features Dr Joshua Hare (Founder & CSO, Longeveron) and Samir Ounzain (Scientific Co-Founder & CEO, HAYA Therapeutics) as well as Hannah-Shmouni, who will be well placed to contribute his expertise on how digital health innovations are transforming aging science and expanding access to precision longevity care.
Longevity.Technology: The role of digital health in longevity has never been more pressing, and Hevolution Foundation’s Global Healthspan Summit provides a pivotal platform for thought leaders to shape the future of healthspan-focused interventions. By integrating endocrinology, AI and multi-omics analytics, Hannah-Shmouni’s work demonstrates how advanced technologies can personalize aging interventions, making them scalable and accessible. Ahead of the event, we spoke with him about how digital health technologies are shaping longevity solutions, the role of AI in transforming endocrine research, and the innovations that are making longevity tools more accessible worldwide.
Hannah-Shmouni explains that digital health technologies are poised to dominate discussions at the Global Healthspan Summit by showcasing their transformative potential in scaling longevity services.
“Tools like AI-powered diagnostics, wearable health monitors, and smart home devices are redefining proactive healthcare by enabling real-time health tracking and personalized interventions from the comfort of one’s home,” he says, adding that these technologies can also bridge gaps between patients and providers, fostering a more connected ecosystem.
“For instance, platforms integrating biomarkers of aging with AI analytics can empower both individuals and clinicians to make data-driven decisions, ultimately extending healthspan,” he explains.
The Summit is likely to emphasize how innovations like these can democratize access to longevity solutions globally, especially in underserved regions. “This is the future: precision, accessibility, and scalability,” says Hannah-Shmouni.
Hannah-Shmouni, who recently collaborated on the chapter Artificial Intelligence in Endocrinology in the book Artificial Intelligence in Clinical Practice, told us that AI is advancing endocrinology by enabling precision medicine at an unprecedented scale.
“It’s transforming how we diagnose, monitor, and treat endocrine disorders by leveraging machine learning algorithms to analyze complex datasets, such as genomic profiles, hormonal patterns, and imaging results,” he explains, offering the example of how AI can predict the onset of diabetes or thyroid dysfunction years before clinical symptoms appear, allowing for earlier intervention.
He adds that, moreover, AI-powered tools are enhancing patient care through personalized treatment plans.
“By integrating data from wearables, salivary hormone testing (like Eli Health’s platform), and other biomarkers, clinicians can tailor therapies to individual needs,” he explains. “This is particularly impactful in conditions like adrenal disorders or metabolic syndrome, where treatment often requires nuanced adjustments. The field is at the dawn of a new era, where AI not only augments clinical decision-making but also democratizes access to high-quality endocrine care globally, bridging gaps in underserved regions.”
When it comes to emerging trends in endocrine research, Hannah-Shmouni explains that these are increasingly focused on precision medicine and the integration of advanced technologies to enhance healthspan and cites senolytics – compounds targeting senescent “zombie” cells that disrupt endocrine function and accelerate aging – as a key area.
“These therapies hold promise for mitigating age-related hormonal decline and chronic diseases,” he explains. “Another trend is the use of AI-driven tools to analyze features of endocrine disorders including advanced face scan technologies through computer vision and cognitive AI architecture, enabling preemptive interventions.”
Salivary hormone testing, like that offered by Eli Health, is also gaining traction for its non-invasive, real-time monitoring capabilities, says Hannah-Shmouni, who explains these can optimize cortisol circadian rhythm and improve quality of life within minutes from sample collection.
“Together, these innovations are reshaping how we approach endocrine health to extend vitality and longevity.”
Genetic factors influence aging, of course, and can influence everything from cellular repair mechanisms to hormonal regulation.
“Variants in genes like FOXO3, associated with longevity, or those involved in telomere maintenance, can determine how well our bodies resist age-related decline,” explains Hannah-Shmouni. “However, even with ‘bad’ genes, lifestyle choices – nutrition, exercise, and stress management – can modify the trajectory of aging. Emerging interventions include gene therapies targeting senescence pathways, and AI-driven tools to identify genetic predispositions for chronic diseases.”
Additionally, advancements in epigenetic reprogramming aim to reverse cellular aging by resetting gene expression patterns.
“In our longevity clinics, including ZOIME in Dubai, UAE, and Supernatural in Toronto, Canada, we use modular multi-omics analysis software, including NU Pro, to analyze large data sets for advanced and personalized recommendations,” explains Hannah-Shmouni. “These innovations, combined with proactive health measures, hold immense promise for extending healthspan and mitigating genetic risks.”
Healthspan Digital Inc, which was founded by Hannah-Shmouni is leveraging technology to promote healthy longevity by integrating advanced smart home tools into everyday life.
“We’ve developed products like AI-powered smart mirrors, that provide real-time health insights and personalized recommendations,” he explains. “These devices, combined with other smart technologies, enable proactive health management directly from home. Our Healthspan Hubs expand this vision by merging medical facilities, wellness centers, and research labs into turnkey solutions for businesses, offering services like biomarker testing, physiological assessments, and AI-driven analytics at very low CAPEX.”
Looking ahead, Healthspan Digital aims to scale these hubs in clinics and real-estate communities, empowering businesses with accessible, precision-driven longevity solutions.
“The ultimate goal is to democratize healthspan advancements, making cutting-edge tools available to individuals and businesses worldwide to scale healthy longevity services.”
To watch the Global Healthspan Summit live today and tomorrow, please go to: www.hevolution.com
